arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

LifeStance Health Group, Inc.

LFST
$10.82 ▲ +0.18 (+1.74%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
26 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

LifeStance Health Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $4.2B
Dividend Yield
Revenue Growth 21.2%
Op. Margin 5.5%
ROIC 0.9%
FCF / Share $0.06
Trailing P/E
Price / Book 2.8x
FCF Yield 0.5%
Debt / Equity 0.19
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$403.48M
↑ +21.2%
Net Income Profit after all expenses
$14.24M
↑ +1908.9%
Operating Margin Operating profit as % of sales
5.5%
↑ +16.7% 33th
FCF / Share Free cash flow per share
$0.06
↑ +31.4%
Long-Term Debt Long-term obligations
$282.75M
— 0.0%

Health Breakdown

Profitability
40
Returns
45
Financial Health
67
Cash Quality
98

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters